PubMed

Systematic review: the effect of preventive lamivudine on hepatitis B reactivation during chemotherapy.

Loomba R, Rowley A, Wesley R, Liang TJ, Hoofnagle JH, Pucino F, Csako G.

Ann Intern Med. 2008 Apr 1;148(7):519-28. Review. Erratum in: Ann Intern Med. 2009 May 5;150(9):657-8. PMID: 18378948 [PubMed - indexed for MEDLINE]Related articlesFree article

Lamivudine prevents reactivation of hepatitis B and reduces mortality in immunosuppressed patients: systematic review and meta-analysis.

Katz LH, Fraser A, Gafter-Gvili A, Leibovici L, Tur-Kaspa R.

J Viral Hepat. 2008 Feb;15(2):89-102. Review.PMID: 18184191 [PubMed - indexed for MEDLINE]Related articles

Prophylactic lamivudine prevents hepatitis B reactivation in chemotherapy patients.

Lim LL, Wai CT, Lee YM, Kong HL, Lim R, Koay E, Lim SG.

Aliment Pharmacol Ther. 2002 Nov;16(11):1939-44.PMID: 12390103 [PubMed - indexed for MEDLINE]Related articlesFree article

Use of lamivudine to prevent hepatitis B virus reactivation during chemotherapy in breast cancer patients.

Yeo W, Ho WM, Hui P, Chan PK, Lam KC, Lee JJ, Johnson PJ.

Breast Cancer Res Treat. 2004 Dec;88(3):209-15.PMID: 15609123 [PubMed - indexed for MEDLINE]Related articles

Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors.

Yeo W, Chan PK, Zhong S, Ho WM, Steinberg JL, Tam JS, Hui P, Leung NW, Zee B, Johnson PJ.

J Med Virol. 2000 Nov;62(3):299-307.PMID: 11055239 [PubMed - indexed for MEDLINE]Related articles

Hepatitis B reactivation after withdrawal of pre-emptive lamivudine in patients with haematological malignancy on completion of cytotoxic chemotherapy.

Hui CK, Cheung WW, Au WY, Lie AK, Zhang HY, Yueng YH, Wong BC, Leung N, Kwong YL, Liang R, Lau GK.

Gut. 2005 Nov;54(11):1597-603. Epub 2005 Jul 6.PMID: 16000641 [PubMed - indexed for MEDLINE]Related articlesFree article

Primary prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with lymphoid malignancies treated with chemotherapy.

Rossi G, Pelizzari A, Motta M, Puoti M.

Br J Haematol. 2001 Oct;115(1):58-62.PMID: 11722410 [PubMed - indexed for MEDLINE]Related articles

Hepatitis B immunoglobulin and Lamivudine improve hepatitis B-related outcomes after liver transplantation: meta-analysis.

Loomba R, Rowley AK, Wesley R, Smith KG, Liang TJ, Pucino F, Csako G.

Clin Gastroenterol Hepatol. 2008 Jun;6(6):696-700. Epub 2008 May 5.PMID: 18456569 [PubMed - indexed for MEDLINE]Related articlesFree article

Lamivudine for the prevention of hepatitis B virus reactivation after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with advanced or relapsed non-Hodgkin's lymphoma single institution experience.

Huang H, Cai Q, Lin T, Lin X, Liu Y, Gao Y, Peng R.

Expert Opin Pharmacother. 2009 Oct;10(15):2399-406.PMID: 19761353 [PubMed - indexed for MEDLINE]Related articles

Lamivudine therapy for prevention of immunosuppressive-induced hepatitis B virus reactivation in hepatitis B surface antigen carriers.

Shibolet O, Ilan Y, Gillis S, Hubert A, Shouval D, Safadi R.

Blood. 2002 Jul 15;100(2):391-6.PMID: 12091327 [PubMed - indexed for MEDLINE]Related articlesFree article

Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis-B surface antigen (HBSAG) seropositive cancer patients undergoing cytotoxic chemotherapy.

Cil T, Altintas A, Pasa S, Bayan K, Ozekinci T, Isikdogan A.

Leuk Lymphoma. 2008 May;49(5):939-47.PMID: 18464113 [PubMed - indexed for MEDLINE]Related articles

Lamivudine in the treatment of hepatitis B virus reactivation during cytotoxic chemotherapy.

Yeo W, Steinberg JL, Tam JS, Chan PK, Leung NW, Lam KC, Mok TS, Johnson PJ.

J Med Virol. 1999 Nov;59(3):263-9.PMID: 10502254 [PubMed - indexed for MEDLINE]Related articles

Preemptive use of interferon or lamivudine for hepatitis B reactivation in patients with aggressive lymphoma receiving chemotherapy.

Leaw SJ, Yen CJ, Huang WT, Chen TY, Su WC, Tsao CJ.

Ann Hematol. 2004 May;83(5):270-5. Epub 2003 Dec 5.PMID: 15060745 [PubMed - indexed for MEDLINE]Related articles

Prophylaxis against chemotherapy-induced reactivation of hepatitis B virus infection with Lamivudine.

Simpson ND, Simpson PW, Ahmed AM, Nguyen MH, Garcia G, Keeffe EB, Ahmed A.

J Clin Gastroenterol. 2003 Jul;37(1):68-71.PMID: 12811213 [PubMed - indexed for MEDLINE]Related articles

Systematic review: lamivudine prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection.

Kohrt HE, Ouyang DL, Keeffe EB.

Aliment Pharmacol Ther. 2006 Oct 1;24(7):1003-16. Review.PMID: 16984494 [PubMed - indexed for MEDLINE]Related articlesFree article

Prevention of hepatitis B virus reactivation in patients with nasopharyngeal carcinoma with lamivudine.

Yeo W, Hui EP, Chan AT, Ho WM, Lam KC, Chan PK, Mok TS, Lee JJ, Mo FK, Johnson PJ.

Am J Clin Oncol. 2005 Aug;28(4):379-84.PMID: 16062080 [PubMed - indexed for MEDLINE]Related articles

Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.

Shepherd J, Jones J, Takeda A, Davidson P, Price A.

Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. Review.PMID: 16904047 [PubMed - indexed for MEDLINE]Related articlesFree article

Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.

Yeo W, Chan TC, Leung NW, Lam WY, Mo FK, Chu MT, Chan HL, Hui EP, Lei KI, Mok TS, Chan PK.

J Clin Oncol. 2009 Feb 1;27(4):605-11. Epub 2008 Dec 15.PMID: 19075267 [PubMed - indexed for MEDLINE]Related articles

A randomized controlled study of preemptive lamivudine in patients receiving transarterial chemo-lipiodolization.

Jang JW, Choi JY, Bae SH, Yoon SK, Chang UI, Kim CW, Cho SH, Han JY, Lee YS.

Hepatology. 2006 Feb;43(2):233-40.PMID: 16440357 [PubMed - indexed for MEDLINE]Related articles

[Effect of lamivudine for hepatitis B virus reactivation in blood cancer patients undergoing immunosuppressive chemotherapy]

Sugimoto R, Enjoji M, Kotoh K, Noguchi K, Tsuruta S, Nakamuta M, Nawata H.

Fukuoka Igaku Zasshi. 2004 Oct;95(10):274-9. Japanese. PMID: 15678886 [PubMed - indexed for MEDLINE]Related articles